Females | Males | |||||
---|---|---|---|---|---|---|
Glucosamine non-users | Glucosamine users | P value | Glucosamine non-users | Glucosamine users | P value | |
N | 188,576 | 53,433 | 163,900 | 30,685 | ||
Age, years | 55.6 ± 8.1 | 59.1 ± 6.8 | < 0.001 | 56.2 ± 8.3 | 58.9 ± 7.5 | < 0.001 |
White, No. (%) | 178,685 (94.8) | 51,366 (96.1) | < 0.001 | 155,205 (94.7) | 29,721 (96.9) | < 0.001 |
Townsend Deprivation Index | − 1.3 ± 3.1 | − 1.8 ± 2.8 | < 0.001 | − 1.2 ± 3.2 | − 1.9 ± 2.8 | < 0.001 |
Body mass index, kg/m2 | 27.0 ± 5.2 | 27.0 ± 4.9 | 0.659 | 27.7 ± 4.2 | 27.7 ± 3.9 | 0.609 |
Smoking status, No. (%) | < 0.001 | < 0.001 | ||||
Never | 112,451 (59.6) | 31,753 (59.4) | 81,245 (49.6) | 14,921 (48.6) | ||
Former | 57,705 (30.6) | 18,682 (35.0) | 60,918 (37.2) | 13,344 (43.5) | ||
Current | 18,420 (9.8) | 2998 (5.6) | 21,737 (13.3) | 2420 (7.9) | ||
Alcohol consumption, times/week | < 0.001 | < 0.001 | ||||
< 1 | 72,232 (38.3) | 17,561 (32.9) | 38,058 (23.2) | 5497 (17.9) | ||
1–2 | 48,838 (25.9) | 13,712 (25.7) | 43,131 (26.3) | 7605 (24.8) | ||
3–4 | 38,116 (20.2) | 12,086 (22.6) | 42,314 (25.8) | 8870 (28.9) | ||
> 4 | 29,390 (15.6) | 10,074 (18.9) | 40,397 (24.6) | 8713 (28.4) | ||
Healthy diet, No. (%) | 52,379 (27.8) | 17,976 (33.6) | < 0.001 | 31,650 (19.3) | 7749 (25.3) | < 0.001 |
Vitamin and mineral supplementation, No. (%) | 63,844 (33.9) | 33,385 (62.5) | < 0.001 | 38,187 (23.3) | 17,238 (56.2) | < 0.001 |
Oily fish supplementation, No. (%) | 46,324 (24.6) | 33,114 (62.0) | < 0.001 | 38,154 (23.3) | 19,864 (64.7) | < 0.001 |
Disease history, No. (%) | ||||||
Diabetes | 6777 (3.6) | 1332 (2.5) | < 0.001 | 11,155 (6.8) | 1481 (4.8) | < 0.001 |
Hypertension | 43,183 (22.9) | 12,660 (23.7) | < 0.001 | 47,857 (29.2) | 8667 (28.2) | < 0.001 |
High cholesterol | 17,959 (9.5) | 5537 (10.4) | < 0.001 | 23,947 (14.6) | 4628 (15.1) | 0.032 |
Osteoarthritis | 13,450 (7.1) | 10,028 (18.8) | < 0.001 | 7503 (4.6) | 4159 (13.6) | < 0.001 |
Rheumatoid arthritis | 2652 (1.4) | 774 (1.4) | 0.466 | 1123 (0.7) | 264 (0.9) | < 0.001 |
Joint pain | 550 (0.3) | 344 (0.6) | < 0.001 | 426 (0.3) | 197 (0.6) | < 0.001 |
Drugs use, No. (%) | ||||||
Antihypertensive | 32,608 (17.3) | 9533 (17.8) | 0.003 | 38,903 (23.7) | 6879 (22.4) | < 0.001 |
Cholesterol-lowering | 23,446 (12.4) | 6969 (13.0) | < 0.001 | 36,307 (22.2) | 6834 (22.3) | 0.644 |
Insulin | 1640 (0.9) | 266 (0.5) | < 0.001 | 2434 (1.5) | 299 (1.0) | < 0.001 |
Aspirin | 18,147 (9.6) | 5774 (10.8) | < 0.001 | 30,099 (18.4) | 5945 (19.4) | < 0.001 |
Ibuprofen | 31,174 (16.5) | 10,834 (20.3) | < 0.001 | 18,075 (11.0) | 5133 (16.7) | < 0.001 |
Paracetamol | 49,286 (26.1) | 14,972 (28.0) | < 0.001 | 27,481 (16.8) | 5585 (18.2) | < 0.001 |
Diuretics | 13,377 (7.1) | 4090 (7.7) | < 0.001 | 10,900 (6.7) | 1942 (6.3) | 0.037 |
Estimated glomerular filtration rate, mL/min/1.73 m2 | 91.5 ± 13.6 | 89.5 ± 12.4 | < 0.001 | 91.1 ± 13.3 | 89.7 ± 12.0 | < 0.001 |
Urate, umol/L | 270.3 ± 66.2 | 271.5 ± 64.2 | < 0.001 | 353.2 ± 70 | 349.9 ± 66.5 | < 0.001 |